Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Flexion Therapeutics Inc | flxn-ex322_7.htm |
| EX-32.1 - EX-32.1 - Flexion Therapeutics Inc | flxn-ex321_6.htm |
| EX-31.2 - EX-31.2 - Flexion Therapeutics Inc | flxn-ex312_8.htm |
| EX-31.1 - EX-31.1 - Flexion Therapeutics Inc | flxn-ex311_9.htm |
| EX-21.1 - EX-21.1 - Flexion Therapeutics Inc | flxn-ex211_1041.htm |
| EX-10.30 - EX-10.30 - Flexion Therapeutics Inc | flxn-ex1030_767.htm |
| EX-10.29 - EX-10.29 - Flexion Therapeutics Inc | flxn-ex1029_766.htm |
| 10-K - 10-K - Flexion Therapeutics Inc | flxn-10k_20161231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S‑8 (Nos. 333-193907, 333-202957 and 333-210111) of Flexion Therapeutics, Inc. of our report dated March 10, 2017 relating to the financial statements, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 10, 2017